About 400 reports

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • United States
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • France
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • Italy
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • United Kingdom
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand
  • Chapter III
  • Transmission of HIV

Acute HIV infection progresses over time to symptomatic HIV infection and then to early symptomatic infection and later, to AIDS (very advanced HIV infection): HIV Infection (acute HIV infection) ----carly asymptomatic HIV infection---ea

  • HIV AIDS
  • China
  • Co. Shanghai Boeringer Ingelheim Pharmaceutical Co., Ltd.
  • Ltd. Beijing Sanjiu Wandong Pharmaceutical Co., Ltd.
  • UNAIDS

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • Italy
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • France
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand

AIDS/ HIV Worldwide Market and Technology Overview A.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand
  • GLOBAL OVERVIEW OF HIV, MEN AND WOMEN, ALL AGES, 1990-2015
  • 2.4.3 Sources Not Used
  • HIV AIDS
  • Asia
  • Japan
  • Forecast
  • UNAIDS
  • Medestea Research & Production S.p.A. - Discovery, 2016
  • Medestea Research & Production S.p.A. - Dormant Developmental Projects,2016
  • HIV AIDS
  • World
  • Product Initiative
  • Supply
  • Medestea
  • 4.1.1 Decreasing HIV related Death Rates
  • GLOBAL HIV PATIENTS DEATH RATE (2012-2016)

AIDS: It is the final and most severe stage of the HIV infection.

  • HIV AIDS
  • World
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

A vaccine that could prevent the HIV infection or stop the development of the disease would greatly support in the fight against the AIDS disease.

  • HIV AIDS
  • Pathology
  • Therapy
  • Vaccine
  • World
  • FUNDING BY THE US GOVERNMENT FOR HIV 2010-2016 ($ BILLIONS)
  • FUNDING BY THE US GOVERNMENT FOR DOMESTIC TREATMENT AND CARE OF HIV 2010-2016 ($ BILLIONS)
  • HIV AIDS
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Global blotting systems market by hospital and diagnostic laboratories 2016-2021 ($ millions)
  • Hospitals and diagnostic laboratories
  • HIV AIDS
  • World
  • Forecast
  • Millipore Corporation
  • Thermo Fisher Scientific, Inc.

HIV

4546 5000 3864
  • WHO clinical staging of HIV/AIDS for adults and adolescents
  • WHO clinical staging of HIV/AIDS for adults and adolescents
  • HIV AIDS
  • Europe
  • United States
  • World
  • Bristol-Myers Squibb Company

AIDS is the advanced stage of HIV infection, and not everyone suffering from HIV infection has AIDS.

  • HIV AIDS
  • Pathology
  • World
  • Forecast
  • POC CD4+ T-cell count
  • HOSPITAL COST FOR LIVER TRANSPLANT
  • HIV AIDS
  • World
  • Alere Inc.
  • DiaSorin S.p.A.
  • Roche Group
  • ART MARKET IN AMERICAS - YEAR OVER YEAR GROWTH 2017-2021
  • Identifying factors impacting market growth
  • HIV AIDS
  • Gilead Sciences, Inc.
  • Hoffmann-La Roche Inc.
  • Janssen Biotech, Inc.
  • ViiV Healthcare Ltd.
  • GROWING CASES OF AIDS/HIV AND INCREASING PREVALENCE OF STDS

Key Market Growth Drivers ##. ## GROWING CASES OF AIDS/ HIV AND INCREASING PREVALENCE OF STDS Increasing cases of HIV is a global issue and governments, organizations, and institutions worldwide are working to reduce the prevalence of this disease.

  • Condom
  • HIV AIDS
  • World
  • Market Size
  • Cupid Limited
  • Identifying Factors that Impede Market Growth
  • HIV rapid test kits market in EMEA
  • HIV AIDS
  • World
  • Market Size
  • Alere Inc.
  • F. Hoffmann-La Roche Ltd.
  • Global HIV-infected People: Statistics 2016
  • Global HIV Infection New Cases: Statistics 2016
  • HIV AIDS
  • World
  • Market Size
  • Church & Dwight Co., Inc.
  • Reckitt Benckiser Group plc
  • Global HIV-infected People: Statistics 2015
  • Global HIV Infection New Cases: Statistics 2015
  • HIV AIDS
  • Sexually Transmitted Disease
  • World
  • Ansell Limited
  • Reckitt Benckiser Group plc

Boehringer Sohn AG & Co KG - Abbott Laboratories - AbbVie Inc Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H##, 2017 Summary GlobalData’s clinical trial report, “Human Immunodeficiency Virus (HIV) Infections (AIDS) Global

  • Clinical Trial
  • HIV AIDS
  • Pathology
  • World

APPROXIMATELY ##% OF HIV/ AIDS PATIENTS IN DEVELOPING COUNTRIES DEPEND ON MYLAN' S ANTIRETROVIRAL THERAPIES.

  • HIV AIDS
  • Canada
  • North America
  • Mylan Inc.
  • Pfizer Inc.